CTI BioPharma (CTIC) – Hot FDA News
-
CTI BioPharma (CTIC) Climbs 37% Following Accelerated FDA Approval of VONJO
-
CTI BioPharma (CTIC) Announces Extension of FDA Review Period for Pacritinib in Myelofibrosis with Severe Thrombocytopenia
-
-
-
-
-
Back to CTIC Stock Lookup